{"id":317,"date":"2026-01-08T00:15:48","date_gmt":"2026-01-08T00:15:48","guid":{"rendered":"https:\/\/emc.health\/?p=317"},"modified":"2026-01-31T13:28:49","modified_gmt":"2026-01-31T13:28:49","slug":"test","status":"publish","type":"post","link":"https:\/\/emc.health\/es\/uncategorized\/test\/","title":{"rendered":"Test"},"content":{"rendered":"

Aqu\u00ed tienes la traducci\u00f3n del art\u00edculo al ingl\u00e9s. He mantenido el tono informativo pero accesible, ideal para un blog de salud dirigido a pacientes (formato “Patient Education”).<\/p>\n\n\n\n

He conservado la estructura y el formato para que puedas copiar y pegar directamente en el editor de WordPress.<\/p>\n\n\n\n

\n\n\n\n

Prostate Cancer: Prevention, Early Detection, and Myths<\/h2>\n\n\n\n

Prostate cancer is one of the most frequent malignancies in men and constitutes one of the leading causes of cancer mortality worldwide. It is estimated that by 2025, the number of new cases will continue to rise in the United States; according to data from the American Cancer Society, approximately 1 in 8 men will be diagnosed with this disease during their lifetime.<\/p>\n\n\n\n

Early detection of prostate cancer significantly increases treatment effectiveness and improves the chances of partial or total remission. To achieve a timely diagnosis, it is necessary to consider both the symptoms reported by the patient (recorded in their medical history) and specific clinical tests that confirm the presence of the disease.<\/p>\n\n\n\n

Likewise, it is fundamental to debunk myths related to preventive check-ups, as these beliefs can create barriers to early detection, reducing the probabilities of successful treatment and remission.<\/p>\n\n\n\n

At Eminat Medical Center<\/strong>, our goal is to inform about risk groups and comorbidities, explain the signs and symptoms requiring medical attention, promote preventive check-ups, and encourage lifestyle changes as key measures for the prevention and early detection of prostate cancer.<\/p>\n\n\n\n

General Overview of Prostate Cancer<\/h3>\n\n\n\n

In theoretical terms, the prostate is a glandular organ of the male reproductive system located below the bladder and in front of the rectum. Prostate cancer is characterized by abnormal cell growth (neoplasia) originating in the acinar or ductal epithelium. This growth is usually slow but can be potentially life-threatening if not detected in time.<\/p>\n\n\n\n

Globally, prostate cancer is the second most frequent cancer in men and represents the fifth leading cause of death from oncological diseases in this population. Incidence and mortality vary between countries: in Latin America, Mexico records the lowest incidence, while Trinidad and Tobago, Cuba, and Venezuela present the highest mortality rates.<\/p>\n\n\n\n

Among the various types of prostate cancer, adenocarcinoma<\/strong> is the most prevalent, derived from the organ’s glandular cells. Other types with lower incidence include small cell neuroendocrine carcinoma, large cell carcinoma, transitional cell carcinoma, and sarcoma.<\/p>\n\n\n\n

Prostate cancer is staged using the Gleason score<\/strong>, which evaluates the degree of cell differentiation from prostate biopsy samples. This scale ranges from 1 to 5, where grade 1 corresponds to cells similar to normal prostate tissue, and grade 5 indicates total differentiation between cancer cells and healthy tissue, the latter being associated with greater aggressiveness and a worse prognosis.<\/p>\n\n\n\n

Understanding the Risks: Why Some Men Are More Vulnerable<\/h3>\n\n\n\n

There are various risk factors associated with the development of prostate cancer, ranging from genetic elements to behavioral or lifestyle factors. The main ones include:<\/p>\n\n\n\n

    \n
  • Age:<\/strong> The incidence and mortality of prostate cancer increase with age. This cancer is more frequent in patients over 50 years old, while it is uncommon in men younger than this.<\/li>\n\n\n\n
  • Family and Genetic History:<\/strong> Having prostate cancer in the family significantly increases risk. Approximately 15% of diagnosed patients have an affected relative, and the risk increases proportionally to the number of relatives with the disease. Brothers and sons show greater susceptibility. Additionally, certain hereditary genetic variants, such as BRCA1 and, to a greater extent, BRCA2, predispose men to develop this cancer.<\/li>\n\n\n\n
  • Ethnicity:<\/strong> Men of African descent show greater susceptibility and a mortality rate 2.4 times higher compared to other races. Asian men show lower incidence, while the Hispanic population presents intermediate risks, varying according to the proportion of African descent in the region.<\/li>\n\n\n\n
  • Lifestyle:<\/strong> Diet and lipid metabolites can influence prostate cell proliferation. High consumption of fatty acids, especially omega-6, and high androgen levels favor prostate cell growth and neoplastic transformation. It has also been suggested that excessive consumption of dairy products and calcium might be related, although a direct causal relationship has not yet been fully confirmed.<\/li>\n\n\n\n
  • Other Risk Factors:<\/strong> Obesity, smoking, a sedentary lifestyle, and a history of prostatitis are also associated with an increased risk of developing prostate cancer.<\/li>\n<\/ul>\n\n\n\n

    What the Body Says: Symptoms of Prostate Cancer<\/h3>\n\n\n\n

    Prostate cancer is a disease that, in its initial stages, is usually asymptomatic. Therefore, diagnosis occurs primarily through preventive check-ups rather than symptoms reported by the patient.<\/p>\n\n\n\n

    As the disease progresses, various symptoms may appear, the presence and severity of which depend on the stage of the cancer. In early phases, the most frequent signs include:<\/p>\n\n\n\n

      \n
    • Decreased urinary flow<\/li>\n\n\n\n
    • Increased urinary frequency<\/li>\n\n\n\n
    • Nocturia (waking up at night to urinate)<\/li>\n\n\n\n
    • Sensation of incomplete bladder emptying<\/li>\n\n\n\n
    • Hematuria (blood in the urine), in a smaller percentage of cases<\/li>\n<\/ul>\n\n\n\n

      It is important to highlight the importance of preventive check-ups, as the symptoms presented in initial stages are similar to Benign Prostatic Hyperplasia<\/strong> (non-cancerous prostate growth). Therefore, a timely diagnosis is key to defining an appropriate therapeutic approach.<\/p>\n\n\n\n

      In advanced stages, patients may present general symptoms of any type of cancer as well as specific manifestations of prostate cancer, including:<\/p>\n\n\n\n

        \n
      • Bone pain (hips, back, chest)<\/li>\n\n\n\n
      • Asthenia and generalized fatigue<\/li>\n\n\n\n
      • Unintentional weight loss<\/li>\n\n\n\n
      • Pathological fractures<\/li>\n\n\n\n
      • Hematuria and hematospermia (blood in semen)<\/li>\n\n\n\n
      • Urinary retention<\/li>\n<\/ul>\n\n\n\n

        The severity and multiplicity of symptoms usually increase as the tumor grows or spreads to other organs (metastasis). This makes the need for early detection evident, which significantly increases the chances of successful treatment and improves the patient’s quality of life.<\/p>\n\n\n\n

        Medical Check-ups and Early Detection: Allies Against Prostate Cancer<\/h3>\n\n\n\n

        Prostate-Specific Antigen (PSA) Blood Test<\/h4>\n\n\n\n

        PSA is a protein produced by prostate cells, present mainly in semen and in smaller amounts in the blood. Since it is found in both normal and cancerous cells, elevated levels of this antigen can suggest the presence of a neoplastic process. This test is usually the first tool for early detection. Normal values in patients without cancer are generally below 4 ng\/ml; higher levels indicate the need for complementary studies.<\/p>\n\n\n\n

        The PSA test offers several advantages. Its main benefit is identifying the disease in initial stages, even in patients who do not yet show symptoms. Furthermore, it allows for an approximate determination of the extent of the disease, as higher values are usually associated with more advanced stages. PSA is also useful for monitoring patient progress throughout treatment and evaluating the efficacy of applied therapies.<\/p>\n\n\n\n

        However, this test has limitations. First, an elevated PSA value is not exclusive to prostate cancer, as it can be due to benign conditions like prostatic hyperplasia or prostatitis. Also, while it indicates the stage of the disease, it does not provide information on the cancer’s aggressiveness. Finally, there are cases where patients with prostate cancer present normal PSA levels, highlighting the need to complement this test with other diagnostic methods.<\/p>\n\n\n\n

        Digital Rectal Exam (DRE)<\/h4>\n\n\n\n

        This consists of a physical examination of the prostate by inserting a lubricated, gloved finger into the rectum to assess size, consistency, shape, and the possible presence of nodules. It is a quick, minimally invasive, and low-cost procedure, although it depends on the operator’s skill and has limited sensitivity.<\/p>\n\n\n\n

        Prostate Biopsy<\/h4>\n\n\n\n

        This is performed when PSA or other complementary tests suggest the presence of cancer. It is an invasive but brief procedure, performed with local anesthesia, in which approximately 12 samples are obtained via a thick needle (transrectal or transperineal). The Gleason score determines the degree of differentiation of the cancerous tissue, from grade 1 (low grade, tissue similar to normal) to grade 5 (high grade, tissue very different from normal), with scores ranging from 2 to 10 points (scores lower than 6 are rare).<\/p>\n\n\n\n

        Complementary Imaging<\/h4>\n\n\n\n
          \n
        • Transrectal Ultrasound:<\/strong> A painless and brief process (10 minutes) where a lubricated probe is inserted into the rectum to assess the prostate. It is also used alongside biopsy to guide the needle for sampling.<\/li>\n\n\n\n
        • Magnetic Resonance Imaging (MRI):<\/strong> Used for soft tissue assessment; provides more detailed images of the prostate and adjacent tissues. Like ultrasound, it is useful for targeted biopsy.<\/li>\n\n\n\n
        • Positron Emission Tomography (PET):<\/strong> A technique based on the intravenous administration of a radioactive substance (tracer or radiotracer, e.g., fluciclovine) that enhances or “paints” cancer cells.<\/li>\n<\/ul>\n\n\n\n

          Age to Start Check-ups<\/h4>\n\n\n\n

          It is recommended to start at age 50<\/strong> for patients without risk factors, and from age 40<\/strong> for those with risk factors. Early detection allows for less invasive treatments and significantly increases survival rates.<\/p>\n\n\n\n

          Active Prevention: How Daily Habits Impact Prostate Health<\/h3>\n\n\n\n

          Just like preventive check-ups, maintaining a healthy lifestyle constitutes a fundamental pillar in prostate cancer prevention. While there is no specific prevention method for this disease, it is possible to control certain modifiable risk factors.<\/p>\n\n\n\n

          The main modifiable factors include diet and physical activity. In dietary terms, the consumption of healthy foods like fruits and vegetables is recommended, along with a reduction in saturated fatty acids, as these can favor abnormal cell proliferation.<\/p>\n\n\n\n

          Physical activity contributes to the reduction of body weight and, consequently, Body Mass Index (BMI). This decreases the influence of obesity as a risk factor\u2014which, while having a lower prevalence, is relevant in the etiology of prostate cancer.<\/p>\n\n\n\n

          Additionally, it is advised to avoid the consumption of toxic substances, such as tobacco and alcohol. These are not only associated with a higher risk of prostate cancer but also increase the likelihood of developing other types of cancer due to their capacity to induce chronic inflammation and genetic damage at the cellular level.<\/p>\n\n\n\n

          Myths and Realities About Prostate Cancer<\/h3>\n\n\n\n

          There are various myths surrounding preventive check-ups and the prognosis of prostate cancer that interfere with early detection. Among the most commonly heard in society are:<\/p>\n\n\n\n

            \n
          • \u201cThe check-up always causes pain\u201d:<\/strong> This myth is one of the main reasons many men avoid preventive exams. It is important to highlight that procedures like the digital rectal exam are minimally invasive, painless, and quick, allowing for an effective initial assessment.<\/li>\n\n\n\n
          • \u201cIf I have no symptoms, I don\u2019t have cancer\u201d:<\/strong> Lack of information generates the false belief that the absence of symptoms guarantees health. in reality, prostate cancer is usually asymptomatic in its initial stages, making preventive check-ups of utmost importance, especially after age 50.<\/li>\n\n\n\n
          • \u201cProstate cancer is always fatal\u201d:<\/strong> Early detection radically changes the prognosis. When diagnosed in initial phases, the cancer is a highly treatable and curable disease, and survival increases the sooner treatment begins.<\/li>\n<\/ul>\n\n\n\n

            Eminat<\/strong> reminds you that taking care of men’s health is not an act of weakness, but of responsibility. Performing preventive check-ups and maintaining healthy habits strengthens the early detection of prostate cancer. Being informed and acting on time can make the difference between timely treatment and serious complications.<\/p>\n\n\n\n

            Protecting your health today guarantees quality of life tomorrow.<\/strong><\/p>","protected":false},"excerpt":{"rendered":"

            Aqu\u00ed tienes la traducci\u00f3n del art\u00edculo al ingl\u00e9s. He mantenido el tono informativo pero accesible, ideal para un blog de salud dirigido a pacientes (formato “Patient Education”). He conservado la estructura y el formato para que puedas copiar y pegar directamente en el editor de WordPress. Prostate Cancer: Prevention, Early Detection, and Myths Prostate cancer […]<\/p>\n","protected":false},"author":7,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"pmpro_default_level":"","inline_featured_image":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-317","post","type-post","status-publish","format-standard","hentry","category-uncategorized","pmpro-has-access"],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/emc.health\/es\/wp-json\/wp\/v2\/posts\/317","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/emc.health\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/emc.health\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/emc.health\/es\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/emc.health\/es\/wp-json\/wp\/v2\/comments?post=317"}],"version-history":[{"count":1,"href":"https:\/\/emc.health\/es\/wp-json\/wp\/v2\/posts\/317\/revisions"}],"predecessor-version":[{"id":318,"href":"https:\/\/emc.health\/es\/wp-json\/wp\/v2\/posts\/317\/revisions\/318"}],"wp:attachment":[{"href":"https:\/\/emc.health\/es\/wp-json\/wp\/v2\/media?parent=317"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/emc.health\/es\/wp-json\/wp\/v2\/categories?post=317"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/emc.health\/es\/wp-json\/wp\/v2\/tags?post=317"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}